Sunday Nguher Uketeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sunday Nguher Uketeh has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Abdulbasit Hamza
Faculty of Veterinary Medicine, University of Ibadan, Ibadan, Nigeria
1 shared publication - Abigail Effiong Obong
Faculty of Pharmacy, University of Uyo, Uyo, Nigeria
1 shared publication - Basirat Oluwadamilola Rufai
Laboratory for Pharmaceutical Profiling & Informatics, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Ibadan, Ibadan, Nigeria
1 shared publication - Emmanuel Abiodun Oyinloye
Department of Microbiology, Faculty of Science, Federal University, Oye-Ekiti, Nigeria
1 shared publication - Fortune Benjamin Effiong
Directorate of Research, TORASIF, Calabar
1 shared publication - Husna Yetunde Aminu
Department of Microbiology, Federal University, Dutsin-Ma, Nigeria
1 shared publication
Latest Publications
- Open Access
- 27 October 2025
- Published by Springer Nature in Discover Public Health
- Vol. 22 (1) , 1-16
Antibiotic use among university students in malaria therapy and its implications for antimicrobial resistance in Nigeria: a quantitative cross-sectional study
Background: Antimicrobial resistance (AMR) is a global health crisis, driven partly by inappropriate antibiotic use. In Nigeria, malaria remains highly prevalent and often mismanaged with antibiotics, particularly in presumed malaria-typhoid co-infections. This study examined patterns of antibiotic use in malaria treatment among university students, highlighting implications for AMR. Methods: A cross-sectional survey was conducted among undergraduates purposively selected from 12 universities across Nigeria’s six geopolitical zones. Data were collected via validated online questionnaires (February–March 2025) and analysed using descriptive statistics, chi-square tests, logistic regression, and Spearman correlation (SPSS v26). Results: Of 646 respondents, > 97% demonstrated general antibiotic knowledge, yet 27.6% misidentified chloroquine as an antibiotic. While 94.6% correctly recognised antibiotics for bacterial infections, about one-fifth believed they were effective against fungal, parasitic, or viral diseases. Despite 84.7% AMR awareness, 49.1% reported using antibiotics for malaria treatment. Misuse was highest in the Northeast (62.3%), Northwest (63.7%), and South-South (32.9%). In the Northeast, key drivers included prior experience (35.4%), pharmacist advice (29.9%), and peer influence (28.0%), while only 6.7% followed physician prescriptions. Misuse correlated with the belief that antibiotics treat all illnesses (r s = 0.329, p < 0.001). Nearly half (49.5%) accessed antibiotics without prescriptions. Conclusions: High AMR awareness contrasts with persistent misuse of antibiotics for malaria, reflecting misconceptions, regional disparities, and weak regulation. Targeted education, stricter antibiotic controls, and improved diagnostics are urgently needed to curb AMR in Nigeria.
- 27 October 2025
- Published by Springer Nature in Discover Public Health
- Vol. 22 (1) , 1-16
Open AccessAntibiotic use among university students in malaria therapy and its implications for antimicrobial resistance in Nigeria: a quantitative cross-sectional study
Background: Antimicrobial resistance (AMR) is a global health crisis, driven partly by inappropriate antibiotic use. In Nigeria, malaria remains highly prevalent and often mismanaged with antibiotics, particularly in presumed malaria-typhoid co-infections. This study examined patterns of antibiotic use in malaria treatment among university students, highlighting implications for AMR. Methods: A cross-sectional survey was conducted among undergraduates purposively selected from 12 universities across Nigeria’s six geopolitical zones. Data were collected via validated online questionnaires (February–March 2025) and analysed using descriptive statistics, chi-square tests, logistic regression, and Spearman correlation (SPSS v26). Results: Of 646 respondents, > 97% demonstrated general antibiotic knowledge, yet 27.6% misidentified chloroquine as an antibiotic. While 94.6% correctly recognised antibiotics for bacterial infections, about one-fifth believed they were effective against fungal, parasitic, or viral diseases. Despite 84.7% AMR awareness, 49.1% reported using antibiotics for malaria treatment. Misuse was highest in the Northeast (62.3%), Northwest (63.7%), and South-South (32.9%). In the Northeast, key drivers included prior experience (35.4%), pharmacist advice (29.9%), and peer influence (28.0%), while only 6.7% followed physician prescriptions. Misuse correlated with the belief that antibiotics treat all illnesses (r s = 0.329, p < 0.001). Nearly half (49.5%) accessed antibiotics without prescriptions. Conclusions: High AMR awareness contrasts with persistent misuse of antibiotics for malaria, reflecting misconceptions, regional disparities, and weak regulation. Targeted education, stricter antibiotic controls, and improved diagnostics are urgently needed to curb AMR in Nigeria.
- Open Access
- 13 September 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (11) , 5528-5532
Two years of COVID-19 vaccination in Nigeria: a review of the current situation of the pandemic: a literature review
Curtailing COVID-19 outbreaks has been the major focus for many countries following the onset of the COVID-19 pandemic. Nigeria expanded its effort with the commencement of its vaccination program against COVID-19 in March 2021 after several less effective interventions as vaccine introduction was implemented. Following the introduction of the vaccines, Nigeria is expected to meet the worldwide COVID-19 eradication target of vaccinating 40% and 70% of the population, respectively, by the end of 2021 and 2022. Nigeria was unable to meet the target at the commencement of the program. The low vaccination rate, attributed to a low acceptance rate of vaccines, a lack of access to vaccines, poor communication, a weak cold-chain system, and inadequate infrastructure in the country, resulted in the complete vaccination of only 15% of the Nigerian populace as of 21 September 2022. To improve the vaccination rate, the COVID-19 Crisis Communication Centre was launched. Also, the implementation of delivery of service, logistics, accountability, supportive supervision, communication, and electronic management of immunization data scaled the vaccination rate to more than 54% of the target populace as of December 2022. Since the introduction of the COVID-19 vaccine, a substantial change in the prevalence and mortality rate has been perceived owing to the country’s progress toward achieving herd immunity against COVID-19. The country ascertained the percentage of cumulative deaths before the vaccination process to be 60.4%, which was reduced to 39.6% post-vaccination. In comparison, the percentage of confirmed COVID-19 cases was reduced from 58.3 to 41.7% post-vaccination. The authors recommend that the government and relevant public health authorities ensure meticulous documentation of the outcomes resulting from vaccination initiatives and facilitate the accessibility of this information to the general public to boost the vaccination rate.
- 13 September 2023
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 85 (11) , 5528-5532
Open AccessTwo years of COVID-19 vaccination in Nigeria: a review of the current situation of the pandemic: a literature review
Curtailing COVID-19 outbreaks has been the major focus for many countries following the onset of the COVID-19 pandemic. Nigeria expanded its effort with the commencement of its vaccination program against COVID-19 in March 2021 after several less effective interventions as vaccine introduction was implemented. Following the introduction of the vaccines, Nigeria is expected to meet the worldwide COVID-19 eradication target of vaccinating 40% and 70% of the population, respectively, by the end of 2021 and 2022. Nigeria was unable to meet the target at the commencement of the program. The low vaccination rate, attributed to a low acceptance rate of vaccines, a lack of access to vaccines, poor communication, a weak cold-chain system, and inadequate infrastructure in the country, resulted in the complete vaccination of only 15% of the Nigerian populace as of 21 September 2022. To improve the vaccination rate, the COVID-19 Crisis Communication Centre was launched. Also, the implementation of delivery of service, logistics, accountability, supportive supervision, communication, and electronic management of immunization data scaled the vaccination rate to more than 54% of the target populace as of December 2022. Since the introduction of the COVID-19 vaccine, a substantial change in the prevalence and mortality rate has been perceived owing to the country’s progress toward achieving herd immunity against COVID-19. The country ascertained the percentage of cumulative deaths before the vaccination process to be 60.4%, which was reduced to 39.6% post-vaccination. In comparison, the percentage of confirmed COVID-19 cases was reduced from 58.3 to 41.7% post-vaccination. The authors recommend that the government and relevant public health authorities ensure meticulous documentation of the outcomes resulting from vaccination initiatives and facilitate the accessibility of this information to the general public to boost the vaccination rate.